Skip to main content
Respiratorius AB logo

Respiratorius AB — Investor Relations & Filings

Ticker · RESP ISIN · SE0023314315 LEI · 5493001YRVZ5XYFEE615 SPGR Professional, scientific and technical activities
Filings indexed 0 across all filing types
Latest filing no filings yet
Country SE Sweden
Listing SPGR RESP

About Respiratorius AB

https://www.respiratorius.com/

Respiratorius AB is a research company focused on the development of innovative drug candidates. The company's primary area of development is oncology, with a specific goal of launching new treatments for aggressive lymphoma. In addition to its cancer program, the company's pipeline has historically included projects for respiratory diseases such as Chronic Obstructive Pulmonary Disease (COPD) and severe asthma. Respiratorius leverages expertise in clinical development, pharmaceutical research, and commercialization to advance its portfolio of potential new medicines.

Recent filings

No filings indexed yet

We are still gathering filings for Respiratorius AB. .

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.